Yayın: Trans-Pd/Pt(II) saccharinate complexes with a phosphine ligand: Synthesis, cytotoxicity and structure-activity relationship
| dc.contributor.author | Aygün, Muhittin | |
| dc.contributor.author | Ulukaya, Engin | |
| dc.contributor.buuauthor | İçsel, Ceyda | |
| dc.contributor.buuauthor | Yılmaz, Veysel T. | |
| dc.contributor.department | Fen Edebiyat Fakültesi | |
| dc.contributor.department | Kimya Bölümü | |
| dc.contributor.orcid | 0000-0002-2849-3332 | |
| dc.contributor.orcid | 0000-0002-2717-2430 | |
| dc.contributor.researcherid | AAI-3342-2021 | |
| dc.contributor.researcherid | L-7238-2018 | |
| dc.contributor.scopusid | 55551960400 | |
| dc.contributor.scopusid | 56441123900 | |
| dc.date.accessioned | 2024-02-13T07:56:40Z | |
| dc.date.available | 2024-02-13T07:56:40Z | |
| dc.date.issued | 2020-05-01 | |
| dc.description.abstract | New trans-[Pd(sac)(2)(PPhMe2)(DMSO)]center dot H2O (Pd) and trans-[Pt(sac)(2)(PPhMe2)(2)]center dot H2O (Pt) complexes (sac = saccharinate and PPhMe 2 = dimethylphenylphosphine) were synthesized and characterized by elemental analysis, IR, NMR, ESI-MS spectral analyses and X-ray diffraction. The complexes were evaluated for their in vitro cytotoxicity against breast (MCF-7), colon (HCT116) and lung (A549) human cancer cell lines. The ATP viability assay displayed that Pd was biologically inactive, but Pt showed significant anticancer potency on MCF-7 cancer cells, similar to cisplatin. The results suggested that Pt targeted DNA, whereas Pd displayed higher binding affinity towards human serum albumin (HSA). Mechanism of action studies of Pt suggested apoptotic cell death due to significant increase in intracellular ROS (reactive oxygen species) levels, mitochondrial damage and formation of DNA double-strand breaks. Finally, this work represents a new example of potent transplatin anticancer complexes. | |
| dc.identifier.citation | İçsel, C. vd. (2020). "Trans-Pd/Pt(II) saccharinate complexes with a phosphine ligand: Synthesis, cytotoxicity and structure-activity relationship". Bioorganic and Medicinal Chemistry Letters, 30(9). | |
| dc.identifier.doi | 10.1016/j.bmcl.2020.127077 | |
| dc.identifier.issn | 0960-894X | |
| dc.identifier.issn | 1464-3405 | |
| dc.identifier.issue | 9 | |
| dc.identifier.pubmed | 32156495 | |
| dc.identifier.scopus | 2-s2.0-85081271622 | |
| dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0960894X20301554 | |
| dc.identifier.uri | https://hdl.handle.net/11452/39657 | |
| dc.identifier.volume | 30 | |
| dc.identifier.wos | 000522861200027 | |
| dc.indexed.scopus | Scopus | |
| dc.indexed.wos | SCIE | |
| dc.language.iso | en | |
| dc.publisher | Pergamon-Elsevier Science | |
| dc.relation.collaboration | Yurt içi | |
| dc.relation.journal | Bioorganic and Medicinal Chemistry Letters | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.relation.tubitak | 215Z230 | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Pharmacology & pharmacy | |
| dc.subject | Chemistry | |
| dc.subject | Trans-Pd/Pt complexes | |
| dc.subject | Saccharinate | |
| dc.subject | Phosphine | |
| dc.subject | DNA damage | |
| dc.subject | Cytotoxicity | |
| dc.subject | Ascites-carcinoma eacs | |
| dc.subject | Antiproliferative activity | |
| dc.subject | Platinum(II) complexe | |
| dc.subject | Anticancer activity | |
| dc.subject | Strand breaks | |
| dc.subject | In-vitro | |
| dc.subject | Palladium(II) | |
| dc.subject | DNA | |
| dc.subject | Cells | |
| dc.subject | Terpyridine | |
| dc.subject.emtree | Antineoplastic agent | |
| dc.subject.emtree | Cisplatin | |
| dc.subject.emtree | Dimethylphenylphosphine | |
| dc.subject.emtree | Human serum albumin | |
| dc.subject.emtree | Palladium complex | |
| dc.subject.emtree | Palladium saccharinate complex | |
| dc.subject.emtree | Phosphine derivative | |
| dc.subject.emtree | Platinum complex | |
| dc.subject.emtree | Platinum saccharinate complex | |
| dc.subject.emtree | Reactive oxygen metabolite | |
| dc.subject.emtree | Unclassified drug | |
| dc.subject.emtree | Antineoplastic agent | |
| dc.subject.emtree | Coordination compound | |
| dc.subject.emtree | DNA | |
| dc.subject.emtree | Organometallic compound | |
| dc.subject.emtree | Palladium | |
| dc.subject.emtree | Platinum | |
| dc.subject.emtree | Reactive oxygen metabolite | |
| dc.subject.emtree | A-549 cell line | |
| dc.subject.emtree | Antineoplastic activity | |
| dc.subject.emtree | Apoptosis | |
| dc.subject.emtree | Article | |
| dc.subject.emtree | BEAS-2B cell line | |
| dc.subject.emtree | Binding affinity | |
| dc.subject.emtree | Cell death | |
| dc.subject.emtree | Cell viability | |
| dc.subject.emtree | Complex formation | |
| dc.subject.emtree | Concentration response | |
| dc.subject.emtree | Controlled study | |
| dc.subject.emtree | Disorders of mitochondrial functions | |
| dc.subject.emtree | DNA damage | |
| dc.subject.emtree | DNA sequence | |
| dc.subject.emtree | Double stranded DNA break | |
| dc.subject.emtree | Drug cytotoxicity | |
| dc.subject.emtree | Drug DNA binding | |
| dc.subject.emtree | Drug efficacy | |
| dc.subject.emtree | Drug mechanism | |
| dc.subject.emtree | Drug potency | |
| dc.subject.emtree | Drug structure | |
| dc.subject.emtree | Drug synthesis | |
| dc.subject.emtree | Gel electrophoresis | |
| dc.subject.emtree | Gene targeting | |
| dc.subject.emtree | HCT 116 cell line | |
| dc.subject.emtree | Human | |
| dc.subject.emtree | Human cell | |
| dc.subject.emtree | IC50 | |
| dc.subject.emtree | In vitro study | |
| dc.subject.emtree | Lipophilicity | |
| dc.subject.emtree | MCF-7 cell line | |
| dc.subject.emtree | Oxidative stress | |
| dc.subject.emtree | Spectrofluorometry | |
| dc.subject.emtree | Stereochemistry | |
| dc.subject.emtree | Structure activity relation | |
| dc.subject.emtree | Cell survival | |
| dc.subject.emtree | Chemistry | |
| dc.subject.emtree | Drug effect | |
| dc.subject.emtree | Molecular model | |
| dc.subject.emtree | Structure activity relation | |
| dc.subject.emtree | Synthesis | |
| dc.subject.emtree | Tumor cell line | |
| dc.subject.mesh | Antineoplastic agents | |
| dc.subject.mesh | Apoptosis | |
| dc.subject.mesh | Cell Line | |
| dc.subject.mesh | Tumor | |
| dc.subject.mesh | Cell Survival | |
| dc.subject.mesh | Coordination complexes | |
| dc.subject.mesh | DNA | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Models, molecular | |
| dc.subject.mesh | Organometallic compounds | |
| dc.subject.mesh | Palladium | |
| dc.subject.mesh | Platinum | |
| dc.subject.mesh | Reactive oxygen species | |
| dc.subject.mesh | Serum albumin, human | |
| dc.subject.mesh | Structure-activity relationship | |
| dc.subject.scopus | Complex; Palladium; 2-Phenylpyridine | |
| dc.subject.wos | Chemistry, medicinal | |
| dc.subject.wos | Chemistry, organic | |
| dc.title | Trans-Pd/Pt(II) saccharinate complexes with a phosphine ligand: Synthesis, cytotoxicity and structure-activity relationship | |
| dc.type | Article | |
| dc.wos.quartile | Q2 (Chemistry, medicinal) | |
| dc.wos.quartile | Q3 (Chemistry, organic) | |
| dc.wos.quartile | Q2 | |
| dc.wos.quartile | Q3 | |
| dspace.entity.type | Publication | |
| local.contributor.department | Fen Edebiyat Fakültesi/Kimya Bölümü | |
| local.indexed.at | PubMed | |
| local.indexed.at | WOS | |
| local.indexed.at | Scopus |
Dosyalar
Lisanslı seri
1 - 1 / 1
